Botulinum toxin for shoulder pain: A cochrane systematic review

Journal of Rheumatology

Volumn 38, Issue 3, 2011, Pages 409-418

  Singh, Jasvinder A ^a,b,c   Fitzgerald, Patrick M ^d  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Benefit; Botulinum toxin; Cochrane systematic review; Safety; Shoulder pain

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; TRIAMCINOLONE;

ABDUCTION; ANALGESIA; COCHRANE LIBRARY; DISABILITY; DRUG WITHDRAWAL; HEMIPLEGIA; HUMAN; JOINT MOBILITY; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SHOULDER PAIN; SHOULDER SPASTICITY; SPASTICITY; STROKE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

BOTULINUM TOXINS; DATABASES, FACTUAL; HUMANS; PAIN MEASUREMENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOULDER PAIN; TREATMENT OUTCOME;

EID: 79952382133     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101081     Document Type: Review

References (52)

1. Bergenudd H, Lindgarde F, Nilsson B, Petersson CJ. Shoulder pain in middle age. A study of prevalence and relation to occupational work load and psychosocial factors. Clin Orthop 1988;231:234-8.
2. Bjelle A. Epidemiology of shoulder problems. Baillieres Clin Rheumatol 1989;3:437-51. (Pubitemid 20043093)
3. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
4. Chakravarty KK, Webley M. Disorders of the shoulder: an often unrecognised cause of disability in elderly people. BMJ 1990;300:848-9. (Pubitemid 20113350)
5. Chard MD, Hazleman R, Hazleman BL, King RH, Reiss BB. Shoulder disorders in the elderly: a community survey. Arthritis Rheum 1991;34:766-9.
6. Croft P, Pope D, Silman A. The clinical course of shoulder pain: prospective cohort study in primary care. BMJ 1996;313:601-2. (Pubitemid 26293647)
7. Pope DP, Croft PR, Pritchard CM, Silman AJ, Macfarlane GJ. Occupational factors related to shoulder pain and disability. Occup Environ Med 1997;54:316-21. (Pubitemid 27245081)
8. Nygren A, Berglund A, von Koch M. Neck and shoulder pain, an increasing problem. Strategies for using insurance material to follow trends. Scand J Rehabil Med Suppl 1995;32:107-12.
9. Wofford JL, Mansfield RJ, Watkins RS. Patient characteristics and clinical management of patients with shoulder pain in U.S. primary care settings: secondary data analysis of the National Ambulatory Medical Care Survey. BMC Musculoskelet Disord 2005;6:4.
10. Turner-Stokes L, Jackson D. Shoulder pain after stroke: a review of the evidence base to inform the development of an integrated care pathway. Clin Rehabil 2002;16:276-98. (Pubitemid 34467220)
11. Chae J, Mascarenhas D, Yu DT, Kirsteins A, Elovic EP, Flanagan SR, et al. Poststroke shoulder pain: its relationship to motor impairment, activity limitation, and quality of life. Arch Phys Med Rehabil 2007;88:298-301. (Pubitemid 46281848)
12. Buchbinder R, Green S, Youd JM, Johnston RV. Oral steroids for adhesive capsulitis. Cochrane Database Syst Rev 2006;CD006189.
13. Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 2003;CD004016.
14. Buchbinder R, Green S, Youd JM, Johnston RV, Cumpston M. Arthrographic distension for adhesive capsulitis (frozen shoulder). Cochrane Database Syst Rev 2008;CD007005.
15. Green S, Buchbinder R, Glazier R, Forbes A. Interventions for shoulder pain. Cochrane Database Syst Rev 2003;CD001156.
16. van der Windt DA, Bouter LM. Physiotherapy or corticosteroid injection for shoulder pain? Ann Rheum Dis 2003;62:385-7.
17. Green S, Buchbinder R, Hetrick S. Acupuncture for shoulder pain. Cochrane Database Syst Rev 2005;CD005319.
18. Cumpston M, Johnston RV, Wengier L, Buchbinder R. Topical glyceryl trinitrate for rotator cuff disease. Cochrane Database Syst Rev 2009;CD006355.
19. Simpson KH. Individual choice of opioids and formulations: strategies to achieve the optimum for the patient. Clin Rheumatol 2002;21 Suppl 1:S5-8.
20. Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain 2002;18 Suppl:S119-24.
21. Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008;64:274-83.
22. Mahowald M, Singh J, Dykstra D. Long term effects of intra-articular botulinum toxin type A on refractory joint pain. Neurotox Res 2006;9:179-88.
23. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107:125-33. (Pubitemid 38058707)
24. Purkiss J, Welch M, Doward S, Foster K. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 2000;59:1403-6. (Pubitemid 30177357)
25. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-80. (Pubitemid 20099439)
26. Wissel J, Muller J, Dressnandt J, Heinen F, Naumann M, Topka H, et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 2000;20:44-9. (Pubitemid 30628581)
27. Gobel H, Heinze A, Heinze-Kuhn K, Jost W. Evidence based medicine: Botulinum toxin A in migraine and tension type headache. J Neurol 2001;248 Suppl:34-8.
28. Cherkin D, Wheeler K, Barlow W, Deyo R. Medication use for low back pain in primary care. Spine 1998;23:607-14. (Pubitemid 28154975)
29. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85:101-5. (Pubitemid 30110749)
30. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain 2002;18 Suppl:S147-54.
31. Hayton MJ, Santini AJ, Hughes PJ, Frostick SP, Trail IA, Stanley JK. Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study. J Bone Joint Surg Am 2005;87:503-7. (Pubitemid 40314998)
32. Wong SM, Hui AC, Tong PY, Poon DW, Yu E, Wong LK. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2005;143:793-7.
33. Keizer SB, Rutten HP, Pilot P, Morre HH, van Os JJ, Verburg AD. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin Orthop Relat Res 2002;401:125-31. (Pubitemid 34832843)
34. Singh JA, Fitzgerald PM. Botulinum toxin for shoulder pain. Cochrane Database Syst Rev 2010;CD008271.
35. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7. (Pubitemid 18029372)
36. Richards R, An KN, Bigliani LU, Friedman RJ, Gartsman GM, Gristina AG, et al. A standardized method for the assessment of shoulder function. J Shoulder Elbow Surg 1994;3:347-52.
37. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538-41. (Pubitemid 29379599)
38. Kwon S, Hartzema AG, Duncan PW, Min-Lai S. Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke 2004;35:918-23. (Pubitemid 38419803)
39. Higgins JP, Altman DG. Assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 500 [updated February 2008]: The Cochrane Collaboration. [Internet. Accessed Nov 15, 2010.] Available from: www.cochrane-handbook.org
40. Cates C. Dr Chris Cates' EBM Web Site. Visual Rx Version 3. [Internet. Accessed Nov 15, 2010.] Available from: http://www.nntonline.net/visualrx/
41. Deeks J, Higgins J, Altman D. Analysing data and undertaking meta-analyses. Cochrane handbook for systematic reviews of interventions version 5.0.0 (updated February 2008): The Cochrane Collaboration. [Internet. Accessed Nov 15, 2010.] Available from: www.cochrane-handbook.org
42. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Presenting results and 'Summary of findings tables'. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 500 [updated February 2008]: The Cochrane Collaboration. [Internet. Accessed Nov 15, 2010.] Available from: www.cochrane-handbook.org
43. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Interpreting results and drawing conclusions. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 500 [updated February 2008]: The Cochrane Collaboration. [Internet. Accessed Nov 15, 2010.] Available from: www.cochrane-handbook.org
44. de Boer KS, Arwert HJ, de Groot JH, Meskers CG, Mishre AD, Arendzen JH, et al. Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. J Neurol Neurosurg Psychiatry 2008;79:581-3. (Pubitemid 351571879)
45. Kong KH, Neo JJ, Chua KS. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin Rehabil 2007;21:28-35. (Pubitemid 46165303)
46. Lim JY, Koh JH, Paik NJ. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke 2008;39:126-31.
47. Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, et al. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. J Rehabil Med 2007;39:440-7. (Pubitemid 47082903)
48. Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry 2007;78:845-8. (Pubitemid 47204590)
49. Singh JA, Mahowald ML, Noorbaloochi S. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Transl Res 2009;153:205-16.
50. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain 2000;88:287-94.
51. Herskowitz A, Herskowitz B. Treatment of neck and shoulder pain with botulinum neurotoxins. Pain Pract 2004;4 Suppl 1:S27-37.
52. Smith H, Audette J, Royal M. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain 2002;18 Suppl:S147-S54.